Life Analysis

ISSN: 3105-9015 (Print)

ISSN: 3105-9023 (Online)

About This Journal
Latest Articles
View more
Recent progress in electrochemiluminescence biosensors based on DNA nanostructures
Jingjing Zhang,Xiaoxu Wang,Jie Chao
Review30 Oct 2026OPEN ACCESS

Electrochemiluminescence (ECL) combines electrochemical triggering with optical readout, giving it high sensitivity, low background, and good spatiotemporal control. DNA nanostructures are attractive in this context because their sequences, shapes, and functional groups can be programmed with nanometer precision. This review surveys how DNA nanotechnology has been used to improve ECL biosensors. We first outline annihilation and co-reactant ECL mechanisms, and then use a structure-activity framework to compare 1D, 2D, and 3D DNA architectures in terms of interfacial ordering, donor-acceptor distance control, and nanoconfinement. We next examine amplification strategies, including HCR, CHA, RCA, and DNA walkers, and discuss DNAzymes, logic circuits, and CRISPR-Cas cascades as emerging functional modules. Applications are grouped by analyte class, covering pathogen nucleic acids, microRNAs, circulating tumor DNA, protein biomarkers, small molecules, metal ions, and intracellular markers. Finally, we highlight challenges related to stability in biological fluids, scalable fabrication, in vivo compatibility, and the sensitivity-dynamic range trade-off, and suggest future directions such as machine-learning-guided DNA nanoengineering, adaptive single-cell ECL platforms, and point-of-care integration.

PDF
Nanopore-based enzyme-linked immunosorbent assay for exosome detection
Xinyao Liu,Yakun Yi,Lei Liu,Haichen Wu
Article24 Sep 2026OPEN ACCESS

Exosomes contain abundant molecular information derived from parental cells and represent promising biomarkers for liquid biopsy. However, current exosome detection methods often suffer from complicated procedures, insufficient sensitivity, and limited applicability in complex biological samples. Herein, we developed a nanopore-based enzyme-linked immunosorbent assay (NELISA) for sensitive exosome analysis. This strategy employs exosomal surface antigens to construct alkaline phosphatase (ALP)-labelled sandwich immunocomplexes, followed by enzymatic conversion of the phosphorylated peptide probe FGpYD8 (where “p” denotes phosphorylation modification). The substrate and product peptides generate distinct current signatures during translocation through a protein nanopore, enabling quantitative analysis through statistical evaluation of nanopore events. By rational selection of capture antibodies, the proposed method enables differential analysis of exosomes from distinct cellular origins and achieves a broad dynamic range of 102–109 particles/mL with a detection limit of 102 particles/mL for HeLa cell-derived exosomes, while maintaining reliable performance in complex biological matrices. This work provides a sensitive and versatile platform for exosome analysis and highlights its potential for exosome-based liquid biopsy applications.

PDF
Photocatalytic self-cleaning and recyclable AuNBPs@TiO2 SERS chip for trace detection and in situ monitoring of methylene blue degradation
Yuanyuan Yao,Jiani Li, Xianqi Fang,Aijie Yu,Baohong Liu
Article10 Sep 2026OPEN ACCESS

Recyclable surface-enhanced Raman scattering (SERS) substrates integrating high sensitivity with effective photocatalytic self-cleaning capability are highly desirable for sustainable pollutant analysis, yet maintaining stable SERS activity during repeated photocatalytic regeneration remains challenging. Herein, a photocatalytic self-cleaning AuNBPs@TiO2 SERS chip was constructed by integrating plasmonic gold nanobipyramids with a photocatalytic TiO2 shell. By regulating the hydrolytic coating process, a uniform TiO2 shell with an optimized thickness of approximately 10 nm was obtained, providing a balance between SERS enhancement and photocatalytic activity. Using methylene blue (MB) as a model organic pollutant, the chip exhibited a wide linear detection range from 10 nM to 1 mM with a low limit of detection of 3.3 nM. The intra-chip and inter-batch relative standard deviations were below 10%, indicating good uniformity and reproducibility. Furthermore, time-dependent SERS spectra enabled in situ monitoring of MB photodegradation under xenon lamp irradiation, with degradation efficiencies exceeding 95% within 90 min for MB concentrations of 10⁻4−10⁻6 M. Independent UV-vis measurements further confirmed MB degradation, showing an 81.91% decrease after 90 min for 10⁻5 M MB. After 12 cycles, the chip retained approximately 72% of its initial SERS signal while maintaining a degradation efficiency above 90%. The AuNBPs@TiO2 chip offers a reusable SERS platform for sensitive MB detection and in situ monitoring of photocatalytic degradation, demonstrating the feasibility of integrating trace detection, photocatalytic regeneration, and repeated use within a single analytical platform.

PDF
Top Downloaded
View more
Targets and strategies for cancer diagnosis and imaging
Peng Gao,Wei Pan,Na Li,Bo Tang
Review31 Jul 2026OPEN ACCESS

Cancer diagnostic imaging is undergoing a fundamental transition from conventional anatomical visualization to molecular-targeted and functionally driven profiling of tumor biology. Next-generation imaging no longer merely detects morphological lesions, but decodes the dynamic biological states underlying tumor initiation, progression, immune remodeling, metabolic reprogramming, and therapeutic response. Imaging targets with high specificity, biological accessibility, and functional relevance are primary drivers of this technological transition. Current cancer imaging targets can be categorized into three spatial layers: extracellular biomarkers, membrane-associated targets, and intracellular biomarkers. Progress in nanotechnology, molecular engineering, bioorthogonal chemistry, and artificial intelligence (AI) has greatly facilitated the construction of multimodal, multi-target, and intelligent imaging systems. Nevertheless, clinical translation still faces prominent obstacles, including tumor heterogeneity, temporal biomarker fluctuation, limited tissue penetration, nonspecific background signals from off-target activation, and translational gaps. This review systematically classifies imaging targets based on their spatial distribution and biological function, summarizes the latest advances in cancer diagnosis and imaging, and discusses emerging research directions and future prospects for next-generation precision oncology.

PDF
Next-generation sequencing-based spatiotemporal transcriptomics: the next wave of spatial transcriptomics
Yiqiao Wang,Jiawei Lin,Zhi Zhu,Shichao Lin,Chaoyong Yang
Review22 Jun 2026OPEN ACCESS

Tissues serve as the functional units of multicellular organisms with intricate spatial organizational complexity. Next-generation sequencing (NGS)-based spatially resolved transcriptomics (SRT) delineates in situ gene expression heterogeneities, establishes high-fidelity associations between transcripts and spatial pixels by segmenting a tissue section into spatial pixels, and elucidates the pivotal roles of cellular spatial organization in biological processes and complex pathological mechanisms. The synergistic integration of nucleic acid barcoding and high-throughput sequencing technologies has rapidly advanced the development of these spatial modalities regarding throughput, resolution, cost-effectiveness, and sensitivity. In this review, we summarize the state-of-the-art sequencing-based spatial transcriptomics, with a primary emphasis on the methodologies. We first introduce two major categories of typical nucleic acid barcoding platforms (in situ barcoding-based and barcoding array-based) used for spatial localization and transcriptome profiling. Then, the burgeoning trend of spatial transcriptomics towards spatiotemporal transcriptomics, which integrates SRT with the temporal dimension to provide more holistic landscapes of gene expression networks, is discussed. We also highlight spatiotemporal transcriptomics based on metabolic RNA labeling that provides unprecedented resolution to resolve transcriptome-wide dynamics in space and time. The emerging applications of these technologies in providing mechanistic insights into complex pathological mechanisms are also discussed. Finally, the perspectives on current bottlenecks and future direction of spatiotemporal transcriptomics are provided.

PDF
Electrochemiluminescence biosensing of biomarkers and bioimaging of cellular functional molecules
Lele Li,Xue Dong,Qin Wei,Huangxian Ju
Review18 Jun 2026OPEN ACCESS

Electrochemiluminescence (ECL) has emerged as a powerful analytical tool for the detection of biomarkers and the imaging of cellular functional molecules, owing to its low background, high sensitivity, and excellent spatiotemporal resolution. This review first summarizes representative classes of ECL luminophores, including organic small molecules, inorganic nanomaterials, and structurally programmable frameworks and polymers, along with their characteristic properties and recent applications. Subsequently, recent advances in ECL biosensing for in vitro detection of biomarkers such as proteins, nucleic acids, and small molecules are discussed, with particular attention to the evolution of target analytes and breakthroughs in achieving ultra-low detection limits. Next, this review focuses on the cutting-edge applications of ECL imaging at single-cell level. By integrating spatial confinement, label-free imaging, and in situ co-reactant generation with diverse signal-amplification strategies, ECL technology enables dynamic, minimally invasive, and high-resolution imaging of single-cell secretions, membrane proteins, and intracellular molecules, underscoring its potential for resolving functional heterogeneity at the single-cell level. Finally, the current challenges and future directions in ECL biosensing and imaging are outlined.

PDF